
Tenolam E 300mg/300mg/600mg Tablet
Salt Composition: Tenofovir Disoproxil Lamivudine and Efavirenz Tablets
Expiry Date: 01/2028
Inclusive of all taxes
30 Tablet
About The Product
HIV infection
Description
Tenolam E 300mg/300mg/600mg Tablet is an anti-HIV medicine which is a combination of antiretrovirals medicines such as Tenofovir Disoproxil Lamivudine and Efavirenz Tablets. It is prescribed to treat HIV (human immunodeficiency virus) infection and delaying progression of HIV-related complications.
It boosts up the immunity to fight against the infection and inhibits the multiplication of virus in the body to control the infection. It should be taken at the same time each day to get effective results.
Don't take more than the recommended dose.
Uses
- HIV infection
Side Effects
Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of Tenolam E 300mg/300mg/600mg Tablet include:
- Bloating, flatulence
- Headache
- Sleeplessness
- Skin reactions
- Wheezing, swelling, or lightheadedness
- Hair loss
- Diarrhea
- Bone disorders
- Weakness
- Anemia
How To Use
- The dosage and treatment duration of the Tenolam E 300mg/300mg/600mg Tablet are decided by the doctor according overall patient's health.
- This tablet should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.
How It Works
- Tenolam E 300mg/300mg/600mg Tablet is an anti-HIV medicine which is a combination of antiretrovirals medicines such as Tenofovir Disoproxil Lamivudine and Efavirenz Tablets.
- They function by preventing the human immunodeficiency virus from multiplying, which reduces the infection's level in your body. Additionally, they raise the number of CD4 cells in your blood, which are white blood cells that fight infection.
Safety Advice
FAQs
Tenolam E 300mg/300mg/600mg Tablet is an antiviral medicine that works by blocking the replication of the virus to reduce its levels in the body.
References
- Arribas, J. R., Pozniak, A. L., Gallant, J. E., DeJesus, E., Gazzard, B., Campo, R. E., ... & Cheng, A. K. (2008). Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(1), 74-78. https://pubmed.ncbi.nlm.nih.gov/17971715/
- Mathias, A. A., Hinkle, J., Menning, M., Hui, J., Kaul, S., Kearney, B. P., & Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team. (2007). Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(2), 167-173. https://pubmed.ncbi.nlm.nih.gov/17667331/
- Avihingsanon, A., Gatechompol, S., Sapsirisavat, V., Thiansanguankul, W., Sophonphan, J., Thammajaruk, N., ... & Ruxrungtham, K. (2017). Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults. International Journal of Infectious Diseases, 61, 89-96. https://pubmed.ncbi.nlm.nih.gov/28627427/
- Deeks, E. D., & Perry, C. M. (2010). Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®) A Review of its Use in the Management of HIV Infection. Drugs, 70(17), 2315-2338. https://pubmed.ncbi.nlm.nih.gov/17266471/
- Sharma, R., & Mehta, K. (2010). Simultaneous spectrophotometric estimation of tenofovir disoproxil fumarate and lamivudine in three component tablet formulation containing efavirenz. Indian journal of pharmaceutical sciences, 72(4), 527. https://pubmed.ncbi.nlm.nih.gov/21218073/
- Frampton, J. E., & Croom, K. F. (2006). Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. Drugs, 66(11), 1501-1512.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
